# A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood

> **NCT05945888** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 68 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3000202
- **DRUG:** Placebo matching BI 3000202

## Key facts

- **NCT ID:** NCT05945888
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-25
- **Primary completion:** 2023-11-13
- **Final completion:** 2023-11-13
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05945888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05945888, "A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05945888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*